BioCryst Pharmaceuticals, Inc. (BCRX)
Biotechnology · Healthcare · $2.3B
Intrinsic Value (Consensus)
$25.88
Current Price
$9.01
Margin of Safety
+187.2%
187.2% Below Intrinsic Value
Value: $26
Price: $9
Valuation Model Estimates
Current Price: $9.01
DCF (Discounted Cash Flow)
$151.97
Graham Number
Not applicable
—
Earnings Power Value
$15.46
Relative Value (P/E)
$36.30
Dividend Discount Model
Not applicable
—
Consensus Value
$25.88
Model Assumptions
Discount Rate
10.3%
Growth Rate
30.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
63
Profitability
10/25
Strength
18/25
Valuation
22/25
Growth
13/25
Financial Health Signals
Declining revenue — top line is shrinking
Strong earnings growth (30% YoY)
High free cash flow yield (15.2%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $1.21
- EPS (Forward)
- $1.27
- Book Value
- $-0.47
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- N/A
- Debt/Equity
- —
- Revenue Growth
- -4.4%
- Earnings Growth
- 30.0%
- Dividend Yield
- N/A
- Beta
- 0.59
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance